Employees: NN (None)Legal category: 5485Size: PMECreation date: 2011-02-14 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOULON (83200), Var
SELARL PHARMACIE MEKATAA : revenue, balance sheet and financial ratios
SELARL PHARMACIE MEKATAA is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOULON (83200),
this company of category PME
shows in 2017 a revenue of 1.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE MEKATAA (SIREN 530320985)
Indicator
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
1 521 460 €
1 688 555 €
Net income
-44 985 €
-20 415 €
-440 902 €
-156 935 €
140 007 €
EBITDA
N/C
N/C
N/C
188 325 €
229 266 €
Net margin
N/C
N/C
N/C
-10.3%
8.3%
Revenue and income statement
In 2020, SELARL PHARMACIE MEKATAA records a net loss of 45 k€. This deficit will reduce equity on the balance sheet.
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-44 985 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1068%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 7%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1067.658%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
6.539%
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
Debt ratio
164.587
189.412
635.663
697.342
1067.658
Financial autonomy
35.263
31.964
11.683
9.845
6.539
Repayment capacity
8.5
8.041
None
None
None
Cash flow / Revenue
8.511%
8.668%
None%
None%
None%
Sector positioning
Debt ratio
1067.662020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average
In 2020, the debt ratio of SELARL PHARMACIE MEKATAA (1067.66) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
6.54%2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Watch
In 2020, the financial autonomy of SELARL PHARMACIE MEKATAA (6.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 58.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
Liquidity ratio
211.342
163.773
82.158
72.406
58.551
Interest coverage
12.683
9.907
None
None
None
Sector positioning
Liquidity ratio
58.552020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Watch
In 2020, the liquidity ratio of SELARL PHARMACIE MEKATAA (58.55) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2020)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2020)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2020)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2020)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE MEKATAA
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
Operating WCR
156 630 €
182 530 €
0 €
0 €
0 €
Inventory turnover (days)
28
28
0
0
0
Customer payment term (days)
3
1
0
0
0
Supplier payment term (days)
33
31
0
0
0
Positioning of SELARL PHARMACIE MEKATAA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE MEKATAA with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE MEKATAA
What is the revenue of SELARL PHARMACIE MEKATAA ?
The revenue of SELARL PHARMACIE MEKATAA in 2017 is 1.5 M€.
Is SELARL PHARMACIE MEKATAA profitable?
SELARL PHARMACIE MEKATAA recorded a net loss in 2020.
Where is the headquarters of SELARL PHARMACIE MEKATAA ?
The headquarters of SELARL PHARMACIE MEKATAA is located in TOULON (83200), in the department Var.
Where to find the tax return of SELARL PHARMACIE MEKATAA ?
The tax return of SELARL PHARMACIE MEKATAA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE MEKATAA operate?
SELARL PHARMACIE MEKATAA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart